| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterococcus faecalis | 92 | 2024 | 251 | 14.400 |
Why?
|
| Gram-Positive Bacterial Infections | 60 | 2024 | 341 | 8.510 |
Why?
|
| Enterococcus | 22 | 2024 | 157 | 6.170 |
Why?
|
| Enterococcus faecium | 18 | 2024 | 102 | 5.370 |
Why?
|
| Staphylococcus aureus | 40 | 2024 | 1451 | 4.960 |
Why?
|
| Endophthalmitis | 33 | 2023 | 262 | 4.790 |
Why?
|
| Eye Infections, Bacterial | 22 | 2019 | 235 | 4.110 |
Why?
|
| Anti-Bacterial Agents | 64 | 2024 | 7181 | 3.200 |
Why?
|
| Bacterial Proteins | 56 | 2021 | 3848 | 3.140 |
Why?
|
| Staphylococcal Infections | 26 | 2024 | 1400 | 3.010 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 13 | 2019 | 567 | 2.710 |
Why?
|
| Genome, Bacterial | 23 | 2021 | 760 | 2.540 |
Why?
|
| Vancomycin Resistance | 12 | 2018 | 128 | 2.380 |
Why?
|
| Bacteriocins | 17 | 2021 | 90 | 2.330 |
Why?
|
| Virulence | 51 | 2021 | 1333 | 2.170 |
Why?
|
| Virulence Factors | 18 | 2022 | 509 | 2.080 |
Why?
|
| Plasmids | 26 | 2018 | 2307 | 2.040 |
Why?
|
| Cytotoxins | 16 | 2004 | 153 | 2.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 10 | 2024 | 687 | 1.920 |
Why?
|
| Gene Expression Regulation, Bacterial | 24 | 2021 | 1122 | 1.920 |
Why?
|
| Genes, Bacterial | 31 | 2020 | 1079 | 1.890 |
Why?
|
| Drug Resistance, Bacterial | 20 | 2024 | 1035 | 1.880 |
Why?
|
| Drug Resistance, Microbial | 17 | 2020 | 862 | 1.770 |
Why?
|
| Teichoic Acids | 7 | 2019 | 66 | 1.660 |
Why?
|
| Cross Infection | 14 | 2020 | 1416 | 1.550 |
Why?
|
| DNA, Bacterial | 20 | 2017 | 1465 | 1.490 |
Why?
|
| Oxazolidinones | 2 | 2020 | 96 | 1.420 |
Why?
|
| Keratitis | 6 | 2020 | 268 | 1.410 |
Why?
|
| Microbial Sensitivity Tests | 32 | 2024 | 1877 | 1.410 |
Why?
|
| Biofilms | 13 | 2021 | 617 | 1.360 |
Why?
|
| Gene Transfer, Horizontal | 7 | 2016 | 145 | 1.320 |
Why?
|
| DNA Transposable Elements | 17 | 2018 | 748 | 1.310 |
Why?
|
| Genomic Islands | 4 | 2010 | 51 | 1.240 |
Why?
|
| Daptomycin | 4 | 2020 | 73 | 1.200 |
Why?
|
| Host-Pathogen Interactions | 9 | 2019 | 1477 | 1.060 |
Why?
|
| Bacteria | 13 | 2023 | 2114 | 0.990 |
Why?
|
| Bacterial Physiological Phenomena | 4 | 2009 | 122 | 0.960 |
Why?
|
| Cell Wall | 9 | 2018 | 422 | 0.960 |
Why?
|
| Gram-Positive Bacteria | 6 | 2014 | 184 | 0.950 |
Why?
|
| Eye Infections | 3 | 2023 | 64 | 0.900 |
Why?
|
| Interspersed Repetitive Sequences | 4 | 2019 | 54 | 0.880 |
Why?
|
| Corneal Ulcer | 6 | 2019 | 169 | 0.870 |
Why?
|
| Streptococcus pneumoniae | 7 | 2022 | 714 | 0.860 |
Why?
|
| Operon | 11 | 2019 | 363 | 0.840 |
Why?
|
| Phylogeny | 14 | 2024 | 2803 | 0.820 |
Why?
|
| Biological Evolution | 5 | 2017 | 1076 | 0.810 |
Why?
|
| Animals, Wild | 1 | 2021 | 90 | 0.780 |
Why?
|
| Terpenes | 1 | 2021 | 98 | 0.780 |
Why?
|
| Aquatic Organisms | 1 | 2021 | 48 | 0.770 |
Why?
|
| Spheniscidae | 1 | 2020 | 8 | 0.770 |
Why?
|
| Vancomycin | 11 | 2018 | 501 | 0.770 |
Why?
|
| Gastrointestinal Tract | 6 | 2017 | 814 | 0.760 |
Why?
|
| Adhesins, Bacterial | 6 | 2014 | 119 | 0.750 |
Why?
|
| Pheromones | 4 | 2015 | 98 | 0.740 |
Why?
|
| Bacterial Capsules | 8 | 2015 | 251 | 0.710 |
Why?
|
| Anti-Infective Agents | 3 | 2024 | 972 | 0.710 |
Why?
|
| Epithelium, Corneal | 6 | 2011 | 247 | 0.670 |
Why?
|
| Methicillin | 1 | 2018 | 59 | 0.660 |
Why?
|
| Colony Count, Microbial | 10 | 2011 | 331 | 0.650 |
Why?
|
| Evolution, Molecular | 7 | 2020 | 1940 | 0.630 |
Why?
|
| Eye Infections, Parasitic | 1 | 2018 | 24 | 0.630 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2018 | 90 | 0.630 |
Why?
|
| Conjugation, Genetic | 8 | 2016 | 126 | 0.620 |
Why?
|
| Probiotics | 1 | 2021 | 351 | 0.600 |
Why?
|
| Polymerase Chain Reaction | 13 | 2023 | 6171 | 0.600 |
Why?
|
| Eye Infections, Viral | 1 | 2018 | 57 | 0.600 |
Why?
|
| Bacterial Toxins | 10 | 2022 | 931 | 0.590 |
Why?
|
| Gelatinases | 4 | 2008 | 94 | 0.590 |
Why?
|
| Ecosystem | 2 | 2020 | 474 | 0.580 |
Why?
|
| Bacteriophages | 6 | 2016 | 356 | 0.570 |
Why?
|
| Hemolysin Proteins | 6 | 1999 | 113 | 0.560 |
Why?
|
| Cornea | 7 | 2020 | 1524 | 0.560 |
Why?
|
| Bacillaceae Infections | 4 | 2005 | 8 | 0.550 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2016 | 47 | 0.540 |
Why?
|
| Conjunctivitis, Bacterial | 1 | 2014 | 24 | 0.500 |
Why?
|
| Staphylococcus epidermidis | 1 | 2015 | 117 | 0.500 |
Why?
|
| Multilocus Sequence Typing | 4 | 2020 | 100 | 0.500 |
Why?
|
| Animals | 83 | 2024 | 168757 | 0.500 |
Why?
|
| Intravitreal Injections | 2 | 2015 | 344 | 0.500 |
Why?
|
| beta-Lactamases | 1 | 2016 | 306 | 0.500 |
Why?
|
| Symbiosis | 5 | 2019 | 287 | 0.490 |
Why?
|
| Streptococcus pyogenes | 2 | 2016 | 289 | 0.490 |
Why?
|
| Uveitis | 1 | 2018 | 375 | 0.480 |
Why?
|
| Inverted Repeat Sequences | 2 | 2012 | 61 | 0.480 |
Why?
|
| Gene Library | 6 | 2020 | 1074 | 0.480 |
Why?
|
| Brazil | 6 | 2021 | 1270 | 0.470 |
Why?
|
| beta-Defensins | 1 | 2013 | 57 | 0.470 |
Why?
|
| Aminoacyltransferases | 1 | 2013 | 51 | 0.460 |
Why?
|
| Quorum Sensing | 3 | 2015 | 131 | 0.460 |
Why?
|
| Genetic Variation | 8 | 2020 | 6544 | 0.440 |
Why?
|
| Bacterial Adhesion | 9 | 2011 | 316 | 0.440 |
Why?
|
| Adaptation, Physiological | 2 | 2019 | 1312 | 0.430 |
Why?
|
| Escherichia coli Infections | 1 | 2016 | 532 | 0.430 |
Why?
|
| Azo Compounds | 1 | 2012 | 113 | 0.420 |
Why?
|
| Pneumococcal Infections | 3 | 2015 | 497 | 0.410 |
Why?
|
| Streptococcus | 5 | 2024 | 197 | 0.400 |
Why?
|
| Multigene Family | 6 | 2021 | 1102 | 0.400 |
Why?
|
| Bioterrorism | 2 | 2002 | 143 | 0.400 |
Why?
|
| Feces | 7 | 2021 | 1401 | 0.390 |
Why?
|
| Gentamicins | 6 | 2018 | 255 | 0.390 |
Why?
|
| Electroretinography | 9 | 2014 | 509 | 0.390 |
Why?
|
| Polysaccharides, Bacterial | 3 | 2019 | 578 | 0.390 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 563 | 0.390 |
Why?
|
| Bacillus cereus | 4 | 2007 | 35 | 0.390 |
Why?
|
| Chromosome Mapping | 5 | 2017 | 4740 | 0.380 |
Why?
|
| Immunity, Innate | 3 | 2019 | 2958 | 0.380 |
Why?
|
| Abscess | 1 | 2014 | 607 | 0.380 |
Why?
|
| Repressor Proteins | 4 | 2014 | 3023 | 0.370 |
Why?
|
| Cataract Extraction | 2 | 2012 | 481 | 0.370 |
Why?
|
| Molecular Sequence Data | 27 | 2012 | 18111 | 0.370 |
Why?
|
| Chromosomes, Bacterial | 2 | 2016 | 282 | 0.370 |
Why?
|
| Carrier State | 2 | 2013 | 518 | 0.350 |
Why?
|
| Humans | 123 | 2024 | 744343 | 0.350 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 839 | 0.340 |
Why?
|
| Vitreous Body | 7 | 2014 | 389 | 0.340 |
Why?
|
| Bacterial Infections | 5 | 2019 | 1401 | 0.340 |
Why?
|
| Sequence Analysis, DNA | 11 | 2017 | 4803 | 0.320 |
Why?
|
| Superoxides | 2 | 2001 | 387 | 0.320 |
Why?
|
| Eye Infections, Fungal | 3 | 2020 | 110 | 0.320 |
Why?
|
| Base Sequence | 20 | 2017 | 12797 | 0.310 |
Why?
|
| Rabbits | 18 | 2021 | 4894 | 0.310 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 1028 | 0.310 |
Why?
|
| Moths | 4 | 2017 | 87 | 0.310 |
Why?
|
| Escherichia coli | 6 | 2016 | 4217 | 0.300 |
Why?
|
| Epidemics | 1 | 2013 | 523 | 0.300 |
Why?
|
| Glycosyltransferases | 2 | 2020 | 113 | 0.290 |
Why?
|
| Stress, Physiological | 5 | 2020 | 1403 | 0.290 |
Why?
|
| Mutagenesis, Insertional | 7 | 2018 | 655 | 0.280 |
Why?
|
| Sex Attractants | 2 | 1995 | 14 | 0.260 |
Why?
|
| Bacteriolysis | 1 | 2005 | 51 | 0.260 |
Why?
|
| Bacillus | 2 | 2003 | 77 | 0.260 |
Why?
|
| RNA, Bacterial | 7 | 2012 | 390 | 0.250 |
Why?
|
| Oxygen | 1 | 2016 | 4189 | 0.250 |
Why?
|
| Inflammasomes | 2 | 2023 | 495 | 0.250 |
Why?
|
| Metalloendopeptidases | 2 | 2012 | 396 | 0.240 |
Why?
|
| Gene Expression | 7 | 2021 | 7799 | 0.240 |
Why?
|
| Swine | 5 | 2022 | 5917 | 0.240 |
Why?
|
| Mutation | 20 | 2020 | 29786 | 0.240 |
Why?
|
| Limbus Corneae | 2 | 2021 | 144 | 0.230 |
Why?
|
| Integrases | 1 | 2006 | 533 | 0.230 |
Why?
|
| Digestive System | 2 | 2003 | 253 | 0.230 |
Why?
|
| Lenses, Intraocular | 1 | 2005 | 140 | 0.230 |
Why?
|
| Prokaryotic Cells | 1 | 2003 | 48 | 0.230 |
Why?
|
| Antifungal Agents | 2 | 2020 | 730 | 0.230 |
Why?
|
| Endocarditis, Bacterial | 3 | 2002 | 455 | 0.230 |
Why?
|
| Mucins | 8 | 2011 | 564 | 0.230 |
Why?
|
| Complement C3 | 1 | 2005 | 461 | 0.230 |
Why?
|
| Eye | 4 | 2004 | 729 | 0.230 |
Why?
|
| Transformation, Bacterial | 2 | 1995 | 78 | 0.220 |
Why?
|
| Hydrogen Peroxide | 3 | 2016 | 731 | 0.220 |
Why?
|
| Serine Endopeptidases | 2 | 2008 | 1072 | 0.220 |
Why?
|
| Awards and Prizes | 1 | 2007 | 375 | 0.220 |
Why?
|
| Amino Acid Sequence | 18 | 2012 | 13815 | 0.220 |
Why?
|
| Prosthesis-Related Infections | 1 | 2008 | 538 | 0.220 |
Why?
|
| Bacteroides | 1 | 2003 | 161 | 0.220 |
Why?
|
| Staphylococcus haemolyticus | 1 | 2021 | 6 | 0.210 |
Why?
|
| Drosophila melanogaster | 2 | 2013 | 1708 | 0.210 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 198 | 0.210 |
Why?
|
| Oxidoreductases | 2 | 2001 | 424 | 0.210 |
Why?
|
| Anthrax | 1 | 2002 | 88 | 0.210 |
Why?
|
| Ciprofloxacin | 2 | 2002 | 315 | 0.210 |
Why?
|
| Cattle | 4 | 2022 | 3922 | 0.210 |
Why?
|
| Vitamin K 2 | 1 | 2001 | 47 | 0.200 |
Why?
|
| Open Reading Frames | 6 | 2014 | 810 | 0.200 |
Why?
|
| Lipopolysaccharides | 3 | 2019 | 2216 | 0.200 |
Why?
|
| Achromobacter | 1 | 2021 | 7 | 0.200 |
Why?
|
| Ophthalmology | 1 | 2007 | 508 | 0.200 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2020 | 639 | 0.200 |
Why?
|
| Dexamethasone | 2 | 2001 | 1951 | 0.190 |
Why?
|
| Bacterial Typing Techniques | 2 | 2018 | 256 | 0.190 |
Why?
|
| Carrier Proteins | 5 | 2013 | 5021 | 0.190 |
Why?
|
| Conjunctivitis | 1 | 2022 | 158 | 0.190 |
Why?
|
| Fusarium | 1 | 2020 | 51 | 0.190 |
Why?
|
| Models, Biological | 8 | 2011 | 9583 | 0.190 |
Why?
|
| Epithelial Cells | 7 | 2012 | 3690 | 0.190 |
Why?
|
| Organ Preservation Solutions | 1 | 2021 | 98 | 0.190 |
Why?
|
| Streptococcus gordonii | 2 | 2017 | 7 | 0.190 |
Why?
|
| Ofloxacin | 1 | 2000 | 65 | 0.190 |
Why?
|
| Prophages | 2 | 2021 | 38 | 0.180 |
Why?
|
| Sigma Factor | 1 | 2021 | 175 | 0.180 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2018 | 1219 | 0.180 |
Why?
|
| Computational Biology | 4 | 2021 | 3521 | 0.180 |
Why?
|
| Serotyping | 3 | 2007 | 338 | 0.180 |
Why?
|
| Penicillin-Binding Proteins | 2 | 2017 | 137 | 0.180 |
Why?
|
| Poultry | 1 | 2019 | 82 | 0.180 |
Why?
|
| Drug Contamination | 1 | 2021 | 147 | 0.180 |
Why?
|
| Ophthalmic Solutions | 1 | 2021 | 317 | 0.170 |
Why?
|
| Genetic Fitness | 1 | 2020 | 121 | 0.170 |
Why?
|
| Aspergillus fumigatus | 1 | 2020 | 150 | 0.170 |
Why?
|
| Bacterial Translocation | 1 | 2019 | 73 | 0.170 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 59 | 0.170 |
Why?
|
| Gene Expression Profiling | 6 | 2014 | 9438 | 0.170 |
Why?
|
| Polymorphism, Genetic | 4 | 2020 | 4328 | 0.170 |
Why?
|
| Neglected Diseases | 1 | 2019 | 64 | 0.170 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2021 | 954 | 0.170 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2019 | 68 | 0.170 |
Why?
|
| Feedback, Physiological | 1 | 2002 | 479 | 0.170 |
Why?
|
| Peptides | 5 | 2014 | 4409 | 0.170 |
Why?
|
| Genes, Essential | 2 | 2017 | 183 | 0.160 |
Why?
|
| Monkey Diseases | 1 | 2018 | 77 | 0.160 |
Why?
|
| History, 21st Century | 2 | 2019 | 1534 | 0.160 |
Why?
|
| Salicylamides | 1 | 2018 | 33 | 0.160 |
Why?
|
| Vesicle-Associated Membrane Protein 2 | 1 | 2018 | 19 | 0.160 |
Why?
|
| Molecular Biology | 1 | 2002 | 596 | 0.160 |
Why?
|
| DNA Primers | 3 | 2018 | 2892 | 0.160 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2018 | 52 | 0.160 |
Why?
|
| Prostheses and Implants | 3 | 2018 | 1387 | 0.160 |
Why?
|
| Carbapenems | 1 | 2019 | 118 | 0.160 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 2018 | 29 | 0.160 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 2012 | 798 | 0.160 |
Why?
|
| Peptidyl Transferases | 1 | 2017 | 54 | 0.150 |
Why?
|
| Agar | 1 | 1997 | 56 | 0.150 |
Why?
|
| Herpes Zoster Ophthalmicus | 1 | 2018 | 36 | 0.150 |
Why?
|
| Endocytosis | 1 | 2002 | 985 | 0.150 |
Why?
|
| Retinoids | 1 | 2018 | 101 | 0.150 |
Why?
|
| Genetic Loci | 3 | 2019 | 2575 | 0.150 |
Why?
|
| CA-125 Antigen | 2 | 2012 | 286 | 0.150 |
Why?
|
| Cloning, Molecular | 8 | 2004 | 4320 | 0.150 |
Why?
|
| Candida albicans | 1 | 2020 | 394 | 0.150 |
Why?
|
| Larva | 2 | 2017 | 519 | 0.150 |
Why?
|
| Genetic Speciation | 1 | 2017 | 46 | 0.150 |
Why?
|
| Carbon | 1 | 2021 | 687 | 0.150 |
Why?
|
| Antigens, Bacterial | 3 | 1999 | 1171 | 0.150 |
Why?
|
| Succinate Dehydrogenase | 1 | 2018 | 146 | 0.150 |
Why?
|
| Genomics | 5 | 2020 | 5720 | 0.150 |
Why?
|
| Glycosylation | 2 | 2018 | 1126 | 0.150 |
Why?
|
| Drug Resistance, Multiple | 1 | 1998 | 252 | 0.150 |
Why?
|
| Congo Red | 2 | 2017 | 46 | 0.150 |
Why?
|
| Membrane Proteins | 6 | 2012 | 7880 | 0.140 |
Why?
|
| Microbial Interactions | 1 | 2017 | 76 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2015 | 3920 | 0.140 |
Why?
|
| Bacteremia | 5 | 2020 | 962 | 0.140 |
Why?
|
| Mice | 20 | 2023 | 81183 | 0.140 |
Why?
|
| Toxoplasma | 1 | 2018 | 150 | 0.140 |
Why?
|
| Herpesvirus 3, Human | 1 | 2018 | 204 | 0.140 |
Why?
|
| Immunocompromised Host | 2 | 2020 | 847 | 0.140 |
Why?
|
| Hospitals | 3 | 2020 | 3952 | 0.140 |
Why?
|
| Herpesvirus 2, Human | 1 | 2018 | 189 | 0.140 |
Why?
|
| Meat | 1 | 2019 | 592 | 0.140 |
Why?
|
| Minocycline | 1 | 2017 | 163 | 0.140 |
Why?
|
| Signal Transduction | 4 | 2009 | 23403 | 0.140 |
Why?
|
| Molecular Structure | 3 | 2018 | 1899 | 0.140 |
Why?
|
| beta-Lactam Resistance | 1 | 2016 | 79 | 0.140 |
Why?
|
| Hypochlorous Acid | 1 | 2015 | 15 | 0.140 |
Why?
|
| Gene Knockout Techniques | 2 | 2016 | 809 | 0.140 |
Why?
|
| Retina | 7 | 2008 | 2616 | 0.140 |
Why?
|
| Botulinum Toxins | 1 | 2018 | 191 | 0.140 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 1708 | 0.140 |
Why?
|
| Species Specificity | 4 | 2012 | 2478 | 0.140 |
Why?
|
| Cell Membrane | 2 | 2018 | 3748 | 0.130 |
Why?
|
| Pyrrolidines | 1 | 2018 | 342 | 0.130 |
Why?
|
| Bacteriological Techniques | 3 | 2021 | 277 | 0.130 |
Why?
|
| Serial Passage | 1 | 2015 | 23 | 0.130 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2014 | 560 | 0.130 |
Why?
|
| Disease Models, Animal | 13 | 2018 | 18029 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2023 | 1809 | 0.130 |
Why?
|
| Erythrocytes | 1 | 2004 | 2455 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 157 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 1836 | 0.130 |
Why?
|
| Lactobacillus | 1 | 1996 | 189 | 0.130 |
Why?
|
| Ampicillin | 1 | 1995 | 139 | 0.130 |
Why?
|
| Phylogeography | 1 | 2014 | 82 | 0.130 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 465 | 0.120 |
Why?
|
| Bacillus thuringiensis | 2 | 2005 | 13 | 0.120 |
Why?
|
| Host-Parasite Interactions | 1 | 1997 | 295 | 0.120 |
Why?
|
| Phagocytosis | 3 | 2016 | 1539 | 0.120 |
Why?
|
| Genetic Complementation Test | 5 | 1995 | 562 | 0.120 |
Why?
|
| Herpes Simplex | 1 | 2018 | 470 | 0.120 |
Why?
|
| Massachusetts | 3 | 2020 | 8663 | 0.120 |
Why?
|
| Aqueous Humor | 1 | 2014 | 161 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3768 | 0.120 |
Why?
|
| RNA, Antisense | 1 | 2014 | 138 | 0.120 |
Why?
|
| Asymptomatic Infections | 1 | 2014 | 128 | 0.120 |
Why?
|
| DNA | 4 | 2005 | 7301 | 0.120 |
Why?
|
| Models, Immunological | 2 | 2015 | 527 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 6 | 2023 | 21827 | 0.110 |
Why?
|
| Conjunctiva | 2 | 2015 | 494 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 4751 | 0.110 |
Why?
|
| Cell Survival | 1 | 2003 | 5882 | 0.110 |
Why?
|
| Electroporation | 1 | 1995 | 251 | 0.110 |
Why?
|
| RNA, Messenger | 9 | 2013 | 13033 | 0.110 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 732 | 0.110 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 675 | 0.110 |
Why?
|
| Intestines | 3 | 2001 | 1924 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2021 | 1253 | 0.110 |
Why?
|
| Transcription Factors | 4 | 2011 | 12208 | 0.110 |
Why?
|
| Hemolysin Factors | 1 | 1992 | 1 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 5867 | 0.110 |
Why?
|
| Archaea | 1 | 2012 | 59 | 0.110 |
Why?
|
| Methylene Blue | 1 | 2013 | 155 | 0.110 |
Why?
|
| Immunogenetic Phenomena | 1 | 2012 | 23 | 0.110 |
Why?
|
| Recombination, Genetic | 3 | 2012 | 1586 | 0.110 |
Why?
|
| Virus Physiological Phenomena | 1 | 2012 | 18 | 0.110 |
Why?
|
| Teicoplanin | 2 | 2011 | 27 | 0.110 |
Why?
|
| Intestinal Mucosa | 2 | 2023 | 3036 | 0.100 |
Why?
|
| Herpesvirus 1, Human | 1 | 2018 | 743 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 2 | 2003 | 264 | 0.100 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2014 | 251 | 0.100 |
Why?
|
| Metalloproteases | 1 | 2012 | 62 | 0.100 |
Why?
|
| Sequence Deletion | 4 | 2012 | 1526 | 0.100 |
Why?
|
| Sunlight | 1 | 2013 | 325 | 0.100 |
Why?
|
| Protein Kinases | 1 | 1999 | 1640 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2001 | 2107 | 0.100 |
Why?
|
| Macaca mulatta | 1 | 2018 | 2375 | 0.100 |
Why?
|
| Macrolides | 2 | 2024 | 201 | 0.100 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2014 | 269 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2003 | 2924 | 0.100 |
Why?
|
| Gene Deletion | 3 | 2014 | 2751 | 0.100 |
Why?
|
| Osteomyelitis | 1 | 2015 | 402 | 0.100 |
Why?
|
| Corneal Diseases | 2 | 2015 | 636 | 0.100 |
Why?
|
| Polyethyleneimine | 1 | 2011 | 63 | 0.100 |
Why?
|
| Methicillin Resistance | 1 | 2012 | 198 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2014 | 5179 | 0.100 |
Why?
|
| Glycine | 2 | 1995 | 671 | 0.100 |
Why?
|
| Culture Media | 3 | 2012 | 908 | 0.100 |
Why?
|
| Tunicamycin | 1 | 2011 | 112 | 0.100 |
Why?
|
| Glycocalyx | 1 | 2012 | 88 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 820 | 0.100 |
Why?
|
| Bioprosthesis | 1 | 2015 | 596 | 0.100 |
Why?
|
| Transcription, Genetic | 5 | 2013 | 7722 | 0.100 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2014 | 266 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2023 | 354 | 0.090 |
Why?
|
| Genetic Vectors | 3 | 2015 | 3420 | 0.090 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 642 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2015 | 1184 | 0.090 |
Why?
|
| Type C Phospholipases | 2 | 2002 | 292 | 0.090 |
Why?
|
| Chemokine CCL20 | 1 | 2010 | 64 | 0.090 |
Why?
|
| Antigens, Surface | 2 | 2008 | 1663 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2018 | 3129 | 0.090 |
Why?
|
| Caenorhabditis elegans | 2 | 2018 | 1419 | 0.090 |
Why?
|
| Protein Subunits | 2 | 2004 | 959 | 0.090 |
Why?
|
| Keratoplasty, Penetrating | 2 | 2021 | 155 | 0.090 |
Why?
|
| Lipid Bilayers | 2 | 2018 | 381 | 0.090 |
Why?
|
| Agriculture | 2 | 2019 | 190 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2019 | 1772 | 0.090 |
Why?
|
| DNA Fingerprinting | 2 | 2001 | 112 | 0.090 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 145 | 0.090 |
Why?
|
| Trachea | 6 | 1997 | 1076 | 0.090 |
Why?
|
| Female | 20 | 2020 | 380194 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1994 | 1375 | 0.080 |
Why?
|
| Caspase 1 | 2 | 2023 | 224 | 0.080 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 1989 | 91 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 871 | 0.080 |
Why?
|
| Photosensitizing Agents | 1 | 2013 | 602 | 0.080 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2008 | 23 | 0.080 |
Why?
|
| Aerobiosis | 2 | 1999 | 106 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2011 | 880 | 0.080 |
Why?
|
| Anaerobiosis | 2 | 1999 | 140 | 0.080 |
Why?
|
| United States | 6 | 2020 | 69872 | 0.080 |
Why?
|
| Ligases | 1 | 2009 | 333 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1989 | 197 | 0.080 |
Why?
|
| Mouth | 1 | 1990 | 374 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 3870 | 0.080 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1989 | 573 | 0.080 |
Why?
|
| Molecular Weight | 4 | 2017 | 2255 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2012 | 2256 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2133 | 0.070 |
Why?
|
| Ecology | 2 | 2002 | 106 | 0.070 |
Why?
|
| Hemolysis | 2 | 2004 | 420 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 913 | 0.070 |
Why?
|
| Cells, Cultured | 6 | 2012 | 19229 | 0.070 |
Why?
|
| Propionibacterium acnes | 1 | 2007 | 66 | 0.070 |
Why?
|
| Genetics, Population | 1 | 2012 | 934 | 0.070 |
Why?
|
| DNA-Binding Proteins | 5 | 2018 | 9648 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 14722 | 0.070 |
Why?
|
| Steroids | 1 | 2012 | 930 | 0.070 |
Why?
|
| Goblet Cells | 2 | 2023 | 287 | 0.070 |
Why?
|
| Florida | 1 | 2007 | 435 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2715 | 0.070 |
Why?
|
| Restriction Mapping | 4 | 2001 | 878 | 0.070 |
Why?
|
| Triazoles | 1 | 2012 | 911 | 0.070 |
Why?
|
| 4-Butyrolactone | 1 | 2006 | 63 | 0.070 |
Why?
|
| Surgical Wound Infection | 2 | 2017 | 1540 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1999 | 1723 | 0.070 |
Why?
|
| Silicone Elastomers | 1 | 2005 | 84 | 0.070 |
Why?
|
| Bile Acids and Salts | 2 | 2009 | 367 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2012 | 3494 | 0.070 |
Why?
|
| Streptolysins | 1 | 2005 | 55 | 0.060 |
Why?
|
| Quinazolines | 1 | 2012 | 1356 | 0.060 |
Why?
|
| Acrylic Resins | 1 | 2005 | 142 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1970 | 0.060 |
Why?
|
| Biodiversity | 1 | 2008 | 341 | 0.060 |
Why?
|
| Genes | 1 | 1989 | 1893 | 0.060 |
Why?
|
| Fas Ligand Protein | 1 | 2005 | 216 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1783 | 0.060 |
Why?
|
| Metagenome | 1 | 2008 | 418 | 0.060 |
Why?
|
| Conserved Sequence | 2 | 1999 | 1202 | 0.060 |
Why?
|
| Escherichia coli Proteins | 1 | 1991 | 1050 | 0.060 |
Why?
|
| Microarray Analysis | 3 | 2012 | 767 | 0.060 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2023 | 48 | 0.060 |
Why?
|
| Male | 15 | 2020 | 350118 | 0.060 |
Why?
|
| Small Molecule Libraries | 1 | 2009 | 720 | 0.060 |
Why?
|
| Surface Plasmon Resonance | 1 | 2004 | 274 | 0.060 |
Why?
|
| Interleukin-1beta | 2 | 2023 | 972 | 0.060 |
Why?
|
| Genotype | 4 | 2007 | 12951 | 0.060 |
Why?
|
| Staphylococcus | 1 | 2024 | 155 | 0.060 |
Why?
|
| Isomerism | 1 | 2023 | 201 | 0.060 |
Why?
|
| DNA Probes | 2 | 1995 | 560 | 0.060 |
Why?
|
| Erythrocyte Membrane | 1 | 2004 | 442 | 0.060 |
Why?
|
| Genetic Linkage | 1 | 1989 | 2421 | 0.060 |
Why?
|
| Crystallization | 1 | 2004 | 524 | 0.060 |
Why?
|
| Biological Warfare | 1 | 2002 | 24 | 0.060 |
Why?
|
| Kinetics | 3 | 2003 | 6473 | 0.050 |
Why?
|
| Cell Line | 5 | 2018 | 15997 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 1736 | 0.050 |
Why?
|
| Animal Diseases | 1 | 2002 | 13 | 0.050 |
Why?
|
| Cytochalasin D | 1 | 2002 | 92 | 0.050 |
Why?
|
| Azithromycin | 1 | 2024 | 196 | 0.050 |
Why?
|
| Adenosine Triphosphate | 3 | 2013 | 2025 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2014 | 4577 | 0.050 |
Why?
|
| Linoleic Acid | 1 | 2023 | 157 | 0.050 |
Why?
|
| Rhodococcus equi | 1 | 2002 | 16 | 0.050 |
Why?
|
| Lysogeny | 1 | 2002 | 67 | 0.050 |
Why?
|
| Genistein | 1 | 2002 | 88 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2015 | 5974 | 0.050 |
Why?
|
| Lipolysis | 1 | 2023 | 210 | 0.050 |
Why?
|
| Chloramphenicol | 2 | 1981 | 75 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 1989 | 1904 | 0.050 |
Why?
|
| Middle Aged | 5 | 2020 | 213383 | 0.050 |
Why?
|
| Base Composition | 1 | 2002 | 293 | 0.050 |
Why?
|
| Carbohydrate Conformation | 1 | 2002 | 208 | 0.050 |
Why?
|
| Bacillus anthracis | 1 | 2002 | 123 | 0.050 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1985 | 404 | 0.050 |
Why?
|
| Fluoroquinolones | 1 | 2024 | 310 | 0.050 |
Why?
|
| Gene Conversion | 1 | 2002 | 71 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2008 | 1053 | 0.050 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2001 | 165 | 0.050 |
Why?
|
| Carbohydrate Sequence | 1 | 2002 | 414 | 0.050 |
Why?
|
| Disease Reservoirs | 1 | 2002 | 131 | 0.050 |
Why?
|
| Zoonoses | 1 | 2002 | 185 | 0.050 |
Why?
|
| Streptococcus sanguis | 1 | 1981 | 16 | 0.050 |
Why?
|
| Polymyxin B | 1 | 2020 | 46 | 0.050 |
Why?
|
| Horses | 1 | 2022 | 304 | 0.050 |
Why?
|
| Benzalkonium Compounds | 1 | 2020 | 24 | 0.050 |
Why?
|
| Colchicine | 1 | 2002 | 243 | 0.050 |
Why?
|
| Eye Banks | 1 | 2021 | 38 | 0.050 |
Why?
|
| Molecular Epidemiology | 2 | 2006 | 468 | 0.050 |
Why?
|
| Trimethoprim | 1 | 2020 | 91 | 0.050 |
Why?
|
| Alleles | 1 | 2012 | 6933 | 0.050 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 2020 | 64 | 0.050 |
Why?
|
| Sorbitol | 1 | 2020 | 59 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2022 | 333 | 0.050 |
Why?
|
| Eye Evisceration | 1 | 2019 | 23 | 0.050 |
Why?
|
| Onchocerciasis, Ocular | 1 | 2019 | 7 | 0.050 |
Why?
|
| Trachoma | 1 | 2019 | 29 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 1682 | 0.040 |
Why?
|
| Eye Enucleation | 1 | 2019 | 128 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2023 | 490 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2002 | 6386 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2021 | 290 | 0.040 |
Why?
|
| Serine-tRNA Ligase | 1 | 1999 | 1 | 0.040 |
Why?
|
| Corneal Perforation | 1 | 2019 | 32 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2018 | 5456 | 0.040 |
Why?
|
| Penicillin Resistance | 1 | 1999 | 84 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 805 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19905 | 0.040 |
Why?
|
| NADH Dehydrogenase | 1 | 1999 | 41 | 0.040 |
Why?
|
| Leprosy | 1 | 2019 | 124 | 0.040 |
Why?
|
| Algorithms | 1 | 2019 | 13881 | 0.040 |
Why?
|
| Research | 1 | 2008 | 1999 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 4149 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2011 | 3444 | 0.040 |
Why?
|
| Catalase | 1 | 1999 | 222 | 0.040 |
Why?
|
| Naphthols | 1 | 2018 | 45 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 2012 | 2645 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2002 | 646 | 0.040 |
Why?
|
| Pneumococcal Vaccines | 1 | 2022 | 391 | 0.040 |
Why?
|
| Uridine Diphosphate N-Acetylmuramic Acid | 1 | 2017 | 29 | 0.040 |
Why?
|
| Ligands | 1 | 2005 | 3282 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1998 | 143 | 0.040 |
Why?
|
| Rats | 4 | 2018 | 24260 | 0.040 |
Why?
|
| Tandem Repeat Sequences | 1 | 1999 | 185 | 0.040 |
Why?
|
| Aged | 3 | 2020 | 163280 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2001 | 1901 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2021 | 369 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2002 | 1547 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 25043 | 0.040 |
Why?
|
| Adult | 4 | 2020 | 214055 | 0.040 |
Why?
|
| Chickens | 1 | 2019 | 865 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2004 | 4011 | 0.040 |
Why?
|
| Mannose-6-Phosphate Isomerase | 1 | 1997 | 5 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2011 | 14557 | 0.040 |
Why?
|
| Cell Division | 2 | 2014 | 4568 | 0.040 |
Why?
|
| Bacteroides Infections | 1 | 1997 | 82 | 0.040 |
Why?
|
| Meningitis, Bacterial | 1 | 1999 | 218 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2002 | 1124 | 0.040 |
Why?
|
| Phenotype | 6 | 2014 | 16365 | 0.040 |
Why?
|
| Chromatography | 1 | 1996 | 206 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2018 | 563 | 0.040 |
Why?
|
| Benzoates | 1 | 2018 | 217 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2008 | 1224 | 0.030 |
Why?
|
| Metagenomics | 1 | 2019 | 428 | 0.030 |
Why?
|
| Amines | 1 | 2017 | 276 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1997 | 2050 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 1997 | 212 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 1989 | 4665 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1996 | 256 | 0.030 |
Why?
|
| Peptidoglycan | 1 | 2017 | 246 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2001 | 1085 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2007 | 3743 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1997 | 462 | 0.030 |
Why?
|
| Macaca | 1 | 2017 | 440 | 0.030 |
Why?
|
| Reading Frames | 1 | 1995 | 18 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2020 | 1959 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 413 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2017 | 698 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2002 | 3144 | 0.030 |
Why?
|
| Oxidants | 1 | 2015 | 164 | 0.030 |
Why?
|
| Ethanolamine | 1 | 2014 | 3 | 0.030 |
Why?
|
| Clone Cells | 1 | 1999 | 1692 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2001 | 788 | 0.030 |
Why?
|
| Proteins | 1 | 2010 | 6103 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 3597 | 0.030 |
Why?
|
| Nucleotidyltransferases | 1 | 1997 | 220 | 0.030 |
Why?
|
| Pyruvaldehyde | 1 | 2014 | 21 | 0.030 |
Why?
|
| Extracellular Space | 1 | 1997 | 594 | 0.030 |
Why?
|
| Adenovirus Infections, Human | 1 | 2015 | 71 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10638 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2699 | 0.030 |
Why?
|
| Life Style | 1 | 2006 | 3835 | 0.030 |
Why?
|
| Doxazosin | 1 | 1994 | 19 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2015 | 718 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 6487 | 0.030 |
Why?
|
| Health Facilities | 1 | 2019 | 573 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1995 | 378 | 0.030 |
Why?
|
| Bacillus subtilis | 1 | 1997 | 359 | 0.030 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 1994 | 24 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2015 | 356 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 12072 | 0.030 |
Why?
|
| Public Health | 1 | 2007 | 2603 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1995 | 462 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 10943 | 0.030 |
Why?
|
| Corneal Stroma | 1 | 2015 | 174 | 0.030 |
Why?
|
| Bronchi | 2 | 1997 | 840 | 0.030 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2013 | 22 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 1792 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2014 | 153 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1994 | 803 | 0.030 |
Why?
|
| Prevalence | 2 | 2018 | 15226 | 0.030 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2013 | 85 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11366 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 85781 | 0.030 |
Why?
|
| Lysine | 1 | 2017 | 1007 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2015 | 500 | 0.030 |
Why?
|
| Fungi | 1 | 2015 | 327 | 0.030 |
Why?
|
| Spectrin | 1 | 1993 | 177 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 57776 | 0.030 |
Why?
|
| Autolysis | 1 | 2012 | 13 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1375 | 0.030 |
Why?
|
| Cell Death | 1 | 2018 | 1706 | 0.030 |
Why?
|
| Alanine | 1 | 2014 | 572 | 0.030 |
Why?
|
| History, 19th Century | 1 | 1994 | 720 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 1992 | 252 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 528 | 0.030 |
Why?
|
| Opsonin Proteins | 1 | 2011 | 150 | 0.030 |
Why?
|
| Ophthalmoscopy | 1 | 1992 | 176 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 56430 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2021 | 2240 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2019 | 1349 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 53288 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 1992 | 219 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 6489 | 0.020 |
Why?
|
| Subtilisins | 1 | 1991 | 83 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2011 | 387 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2019 | 880 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 1994 | 640 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1995 | 1154 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 4386 | 0.020 |
Why?
|
| beta-Lactams | 1 | 2012 | 160 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 712 | 0.020 |
Why?
|
| Lyngbya Toxins | 1 | 1989 | 6 | 0.020 |
Why?
|
| Biological Transport | 1 | 2014 | 2118 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13102 | 0.020 |
Why?
|
| Lepidoptera | 1 | 2009 | 23 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2014 | 6196 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 683 | 0.020 |
Why?
|
| Crystallography, X-Ray | 2 | 2004 | 2011 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2014 | 689 | 0.020 |
Why?
|
| Thrombospondin 1 | 1 | 2011 | 250 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1995 | 1189 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2014 | 681 | 0.020 |
Why?
|
| Amino Acids | 2 | 1992 | 1736 | 0.020 |
Why?
|
| Acids | 1 | 2009 | 127 | 0.020 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2008 | 43 | 0.020 |
Why?
|
| Titanium | 1 | 2011 | 494 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4204 | 0.020 |
Why?
|
| Temperature | 1 | 2015 | 2206 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2012 | 673 | 0.020 |
Why?
|
| Tight Junctions | 1 | 2011 | 311 | 0.020 |
Why?
|
| Pneumocystis | 1 | 1988 | 57 | 0.020 |
Why?
|
| Anterior Chamber | 1 | 2008 | 197 | 0.020 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2008 | 177 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 1683 | 0.020 |
Why?
|
| Gene Frequency | 1 | 1995 | 3588 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 1990 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 1364 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 319 | 0.020 |
Why?
|
| Health Promotion | 1 | 2019 | 2205 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3701 | 0.020 |
Why?
|
| Developing Countries | 1 | 2019 | 2815 | 0.020 |
Why?
|
| Chest Pain | 1 | 2014 | 1114 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2008 | 204 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 1991 | 638 | 0.020 |
Why?
|
| Incidence | 2 | 2018 | 20947 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8301 | 0.020 |
Why?
|
| Phacoemulsification | 1 | 2008 | 149 | 0.020 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2006 | 133 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 2013 | 807 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1994 | 2740 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15295 | 0.020 |
Why?
|
| Lymphokines | 1 | 1989 | 949 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2008 | 4217 | 0.020 |
Why?
|
| Antioxidants | 1 | 1994 | 1663 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2008 | 475 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1989 | 881 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39050 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2564 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 964 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2008 | 758 | 0.020 |
Why?
|
| Staphylococcal Protein A | 1 | 1985 | 40 | 0.020 |
Why?
|
| Flagella | 1 | 2005 | 103 | 0.020 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 2004 | 13 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2088 | 0.020 |
Why?
|
| Polyvinyl Chloride | 1 | 2004 | 34 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2171 | 0.020 |
Why?
|
| Immunity | 1 | 1991 | 1012 | 0.020 |
Why?
|
| Polypropylenes | 1 | 2004 | 64 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 634 | 0.020 |
Why?
|
| Apoptosis | 2 | 2013 | 9727 | 0.020 |
Why?
|
| Iodides | 1 | 2004 | 41 | 0.020 |
Why?
|
| Plasminogen Activators | 1 | 1985 | 209 | 0.020 |
Why?
|
| DNA Repair | 1 | 2013 | 2046 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2019 | 9146 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 1994 | 2046 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 2 | 1981 | 570 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 1401 | 0.010 |
Why?
|
| Immune Sera | 1 | 2004 | 641 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1990 | 1354 | 0.010 |
Why?
|
| DNA Damage | 1 | 2013 | 2432 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3086 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2004 | 407 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 768 | 0.010 |
Why?
|
| Dogs | 3 | 1993 | 3912 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.010 |
Why?
|
| Dimerization | 1 | 2004 | 893 | 0.010 |
Why?
|
| Ethanol | 1 | 2009 | 1342 | 0.010 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2002 | 48 | 0.010 |
Why?
|
| Blindness | 1 | 2007 | 617 | 0.010 |
Why?
|
| Streptomycin | 2 | 1992 | 69 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 2001 | 31 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10252 | 0.010 |
Why?
|
| Health Policy | 1 | 2014 | 2661 | 0.010 |
Why?
|
| Blotting, Northern | 2 | 1994 | 1581 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16689 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 5391 | 0.010 |
Why?
|
| Child | 2 | 2020 | 77709 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2014 | 3528 | 0.010 |
Why?
|
| R Factors | 1 | 1981 | 44 | 0.010 |
Why?
|
| Morbidity | 1 | 2007 | 1769 | 0.010 |
Why?
|
| Trypsin | 1 | 2002 | 511 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1989 | 6314 | 0.010 |
Why?
|
| Europe | 1 | 2008 | 3339 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2001 | 448 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3589 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1998 | 15540 | 0.010 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2002 | 362 | 0.010 |
Why?
|
| Actins | 1 | 2007 | 2121 | 0.010 |
Why?
|
| Epithelium | 2 | 1997 | 1679 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 5892 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 77449 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1994 | 2839 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 2002 | 464 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1799 | 0.010 |
Why?
|
| Prognosis | 2 | 2007 | 29063 | 0.010 |
Why?
|
| Neurons | 1 | 2018 | 9338 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1263 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 1155 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3505 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1989 | 5524 | 0.010 |
Why?
|
| Epitopes | 1 | 1985 | 2571 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 794 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1997 | 441 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1997 | 3772 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1999 | 41006 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 9274 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 6114 | 0.010 |
Why?
|
| Mucin-2 | 1 | 1995 | 49 | 0.010 |
Why?
|
| Time Factors | 2 | 1995 | 40075 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1995 | 203 | 0.010 |
Why?
|
| Probucol | 1 | 1994 | 23 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1994 | 46 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 1994 | 105 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 3760 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 1994 | 182 | 0.010 |
Why?
|
| Spectinomycin | 1 | 1992 | 9 | 0.010 |
Why?
|
| Infant | 1 | 2015 | 35136 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 23338 | 0.010 |
Why?
|
| Erythromycin | 1 | 1992 | 120 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 72290 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1992 | 252 | 0.010 |
Why?
|
| Glucose | 1 | 2004 | 4397 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 6622 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 9386 | 0.010 |
Why?
|
| Detergents | 1 | 1992 | 230 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1997 | 2008 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 4161 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1992 | 791 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1991 | 344 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4420 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1994 | 1032 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 1994 | 976 | 0.010 |
Why?
|
| Cricetinae | 1 | 1992 | 2472 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1992 | 772 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1991 | 40561 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1994 | 2187 | 0.000 |
Why?
|
| Glycopeptides | 1 | 1989 | 224 | 0.000 |
Why?
|
| Methods | 1 | 1988 | 1129 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 2186 | 0.000 |
Why?
|
| Cystic Fibrosis | 1 | 1994 | 1177 | 0.000 |
Why?
|
| Antibodies | 1 | 1992 | 2460 | 0.000 |
Why?
|
| Monocytes | 1 | 1994 | 2596 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1991 | 2126 | 0.000 |
Why?
|
| Kanamycin | 1 | 1981 | 64 | 0.000 |
Why?
|
| Reference Values | 1 | 1988 | 4982 | 0.000 |
Why?
|
| DNA Replication | 1 | 1981 | 1399 | 0.000 |
Why?
|